au.\*:("RABINOVICH, Regina")
Results 1 to 17 of 17
Selection :
Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine advisory CommitteeARVIN, Ann M; FAST, Patricia; MYERS, Martin et al.Clinical infectious diseases. 2004, Vol 39, Num 2, pp 233-239, issn 1058-4838, 7 p.Article
The transfer of vaccine technology to developing countries: the Latin American experienceHOMMA, A; KNOUSS, R. F.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 47-54, issn 0266-4623Conference Paper
Desirable immunologic characteristics for the development of an ideal vaccineADA, G.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 71-80, issn 0266-4623Conference Paper
The contribution of immunization to economic developmentPARKER, D; HILL, T.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 21-29, issn 0266-4623Conference Paper
The role of vaccine research and development in the scientific development of middle-income countriesMARTINEZ-PALOMO, A; LOPEZ-CERVANTES, M; FREEMAN, P et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 30-38, issn 0266-4623Conference Paper
Effective mucosal immunity: current concepts for vaccine delivery and immune response analysisMCGHEE, J. R; KIYONO, H.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 93-106, issn 0266-4623Conference Paper
Immunization of the neonateLAWTON, A. R.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 154-160, issn 0266-4623Conference Paper
Conference on vaccines and public healthFREEMAN, Phyllis; RABINOVICH, Regina; ROBBINS, Anthony et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, issn 0266-4623, 198 p.Conference Proceedings
Live attenuated vaccine vectorsMEKALANOS, J. J.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 131-142, issn 0266-4623Conference Paper
Novel approaches to controlled-release antigen deliveryCOHEN, S; ALONSO, M. J; LANGER, R et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 121-130, issn 0266-4623Conference Paper
Synthetic peptides and purified antigens as vaccinesBROWN, F.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 161-166, issn 0266-4623Conference Paper
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian childrenBOJANG, Kalifa A; OLODUDE, Folasade; RABINOVICH, Regina et al.Vaccine. 2005, Vol 23, Num 32, pp 4148-4157, issn 0264-410X, 10 p.Article
The global capacity for manufacturing vaccines: prospects for competition and collaboration among producers in the next decadeROBBINS, A; ARITA, I.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 39-46, issn 0266-4623Conference Paper
Adjuvants and immune enhancementALLISON, A. C.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 107-120, issn 0266-4623Conference Paper
Maternal immunization to prevent infectious diseases in the neonate or infantINSEL, R. A; AMSTEY, M; WOODIN, K et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 143-153, issn 0266-4623Conference Paper
Modern concepts in immune recognition and lymphocyte activation: relevance for the development of useful vaccinesGERMAIN, R. N.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 81-92, issn 0266-4623Conference Paper
The thermostability of vaccines: technologies for improving the thermostability of the oral poliovirus vaccineLEMON, S. M; MILSTIEN, J. B.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 177-184, issn 0266-4623Conference Paper